Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 2 5Phase 4 3Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 3Recruiting 2

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Gastrointestinal 1Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thromboembolism 1Pulmonary Embolism 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Hemorrhage 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Dalteparin × Clear all
NCT00942968 2024-04-18

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Pfizer

Phase 4 Completed
338 enrolled 21 charts
Tumor-Agnostic

Neoplasms

NCT00966277 2016-12-12

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 4 Completed
87 enrolled 9 charts
Classical hematologyGastrointestinal

Pancreatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT01741506 2015-06-23

COPPVATS

Aarhus University Hospital

Phase 4 Completed
116 enrolled
Thoracic

Hemorrhage, Lung Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡